Dr. Chapekis studies treatments and devices that help improve recovery and outcomes for patients with heart issues. He has researched the effectiveness of specific medications and devices used during procedures like cardiac catheterizations and coronary stenting. For instance, he has explored how the Angio-Seal device helps patients heal more quickly after heart surgeries, as well as how different blood-thinning treatments can impact patients experiencing unstable angina, which is a serious form of chest pain due to reduced blood flow to the heart.
Key findings
The 6Fr Angio-Seal device allows patients to walk sooner after heart surgery without introducing new risks, improving recovery times following cardiac catheterizations.
In a trial comparing treatments for unstable angina, 71% of patients using recombinant hirudin showed better blood clotting levels compared to only 16% of patients treated with heparin.
Stent thrombosis occurred in 11.7% of patients with flexible coil coronary stents, highlighting the importance of monitoring clot formation and adjusting blood-thinning treatments.
Frequently asked questions
Does Dr. Chapekis study unstable angina?
Yes, he has researched treatment options for unstable angina, particularly comparing the effectiveness of different blood-thinning medications.
What treatments has Dr. Chapekis investigated?
He has investigated the use of the Angio-Seal device and recombinant hirudin as treatments to improve patient outcomes following heart-related procedures.
Is Dr. Chapekis's work relevant to patients with heart stents?
Yes, his research on stent thrombosis provides important insights for patients with coronary stents, aiming to improve their treatment and reduce complications.
Publications in plain English
The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry.
2001
The American journal of cardiology
Kapadia SR, Raymond R, Knopf W, Jenkins S, Chapekis A +8 more
Plain English Researchers studied the 6Fr Angio-Seal device, which is used to close the artery after heart procedures, to see how safe and effective it is. They found that this device helps patients walk sooner after surgery without introducing new risks. Specifically, it allows for efficient recovery following cardiac catheterizations, making it an important tool in patient care.
Who this helps: This helps patients recovering from heart procedures.
Plain English This study compared two treatments for unstable angina, a type of chest pain caused by reduced blood flow to the heart. Researchers found that patients treated with recombinant hirudin showed more improvement in heart artery blockage than those treated with heparin. Specifically, 71% of the patients receiving hirudin had better clotting levels compared to just 16% with heparin, and hirudin also improved key measurements of artery size and narrowing.
Who this helps: This research benefits patients with unstable angina by exploring a potentially more effective treatment option.
Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome.
1993
Journal of the American College of Cardiology
Nath FC, Muller DW, Ellis SG, Rosenschein U, Chapekis A +3 more
Plain English This study looked at complications that can happen after placing a flexible coil stent in the coronary arteries of 145 patients. Researchers found that stent thrombosis, where a clot forms at the site of the stent, occurred in 11.7% of the cases, with 7 cases happening within 24 hours and 10 within 21 days. This issue is linked to serious problems like heart attacks and may be less frequent if patients receive stronger blood-thinning treatments, although too much can lead to bleeding.
Who this helps: This benefits patients undergoing coronary stenting, as it provides insights to improve their treatment and outcomes.